Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19. (October 2020)

• Record Type: Journal Article
• Authors: Monti, Giulia; Giovannini, Giada; Marudi, Andrea; Bedin, Roberta; Melegari, Alessandra; Simone, Anna Maria; Santangelo, Mario; Pignatti, Alessandro; Bertellini, Elisabetta; Trenti, Tommaso; Meletti, Stefano
• Is Part Of: Seizure. Volume 81(2020)
• Page Start: 18
• Page End: 20
• Publication Date: 2020-10
• Subjects: NORSE -- Anti-NMDA-R encephalitis -- COVID-19 -- Status epilepticus -- Autoimmune diseases; Epilepsy -- Periodicals; Epilepsy -- Periodicals; Seizures -- Periodicals; Épilepsie -- Périodiques; Electronic journals; Electronic journals; 616.853
• DOI: 10.1016/j.seizure.2020.07.006
• Languages: English
• ISSNs: 1059-1311

Abstract

Highlights: Autoimmune encephalitis and status epilepticus in COVID-19 can be challenging. Immunotherapy could be useful for anti-NMDAr encephalitis and SARS-Cov-2 infection. Cytokines storm could play a role for NORSE presentation in NDMA-R encephalitis.